Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1992-10-16
1995-05-09
Moody, Patricia R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514 75, 514177, 514178, 514179, 514182, 536 5, 552502, 552540, 562 8, A61K 3156, A61K 3166
Patent
active
054139961
ABSTRACT:
The invention provides compounds of the formula ##STR1## or a pharmaceutically acceptable salt thereof, wherein [D] is the residue of a drug having a reactive functional group, said functional group being attached, directly or through a bridging group, via an oxygen-phosphorus bond to the phosphorus atom of the ##STR2## moiety; R.sub.1 is C.sub.1 -C.sub.8 alkyl, C.sub.6 -C.sub.10 aryl or C.sub.7 -C.sub.12 aralkyl; R.sub.2 is hydrogen, C.sub.1 -C.sub.8 alkyl, C.sub.6 -C.sub.10 aryl, C.sub.4 -C.sub.9 heteroaryl, C.sub.3 -C.sub.7 cycloalkyl, C.sub.3 -C.sub.7 cycloheteroalkyl or C.sub.7 -C.sub.12 aralkyl; and R.sub.3 is selected from the group consisting of C.sub.1 -C.sub.8 alkyl; C.sub.2 -C.sub.8 alkenyl having one or two double bonds; (C.sub.3 -C.sub.7 cycloalkyl)--C.sub.r H.sub.2r -- wherein r is zero, one, two or three, the cycloalkyl portion being unsubstituted or bearing 1 or 2 C.sub.1 -C.sub.4 alkyl substituents on the ring portion; (C.sub.6 -C.sub.10 aryloxy)C.sub.1 -C.sub.8 alkyl; 2-, 3- or 4-pyridyl; and phenyl--C.sub.r H.sub.2r -- wherein r is zero, one, two or three and phenyl is unsubstituted, or is substituted by 1 to 3 alkyl each having 1 to 4 carbon atoms, alkoxy having 1 to 4 carbon atoms, halo, trifluoromethyl, dialkylamino having 2 to 8 carbon atoms or alkanoylamino having 2 to 6 carbon atoms. The compounds are adapted for targeted drug delivery, especially to the brain.
REFERENCES:
patent: 3929840 (1975-12-01), Christensen et al.
patent: 4540564 (1985-09-01), Bodor
patent: 4703043 (1987-10-01), Karanewsky et al.
patent: 4816570 (1989-03-01), Farquhar
patent: 4968788 (1990-11-01), Farquhar
Iyer et al, Tetrahedron Letters, vol. 30, No. 51, 1989, pp. 7141-7144.
Chemical Abstracts, vol. 112, 1990, abstract No. 69487n, Freed et al.
Farquhar et al, J. Pharm. Sci., vol. 72, No. 3, Mar. 1983, 324-325.
Srivastva et al, Bioorganic Chemistry 12 (1984), 118-129.
Prisbe et al, J. Med. Chem., 1986, 29, 671-675.
Mitsuya et al, Science, vol. 249, 28 Sep. 1990, 1533-1544.
Moody Patricia R.
University of Florida
LandOfFree
Targeted drug delivery via phosphonate derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeted drug delivery via phosphonate derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeted drug delivery via phosphonate derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1705440